![Redefining loading bay operations with Gandhi Automations' dock leveler solutions Redefining loading bay operations with Gandhi Automations' dock leveler solutions](https://cdn.magzter.com/1394808148/1727680168/articles/OvesqKbns1729753582777/REDEFINING-LOADING-BAY-OPERATIONS-WITH-GANDHI-AUTOMATIONS-DOCK-LEVELER-SOLUTIONS.jpg)
At Gandhi Automations, we are proud to be recognised as India's No.1 Entrance Automation and Loading Bay Equipment Company. This achievement is the result of our relentless pursuit of excellence, innovation, and a steadfast commitment to delivering quality. Over the years, we have earned a reputation for providing reliable solutions backed by exceptional customer service. Our dedication to maintaining the highest standards is reflected in our certifications, including EN ISO 9001:2015, EN ISO 14001:2015, and ISO 45001:2018, accredited by TÜV Austria.
Since our inception in 1996, we have been at the forefront of manufacturing, importing, distributing, and installing products that are both reliable and user-friendly.
Denne historien er fra October 2024-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra October 2024-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
![Pharma's strategic path to growth in the nutra maze Pharma's strategic path to growth in the nutra maze](https://reseuro.magzter.com/100x125/articles/5843/1981257/S7RL7urj51738585009245/PHARMAS-STRATEGIC-PATH-TO-GROWTH-IN-THE-NUTRA-MAZE.jpg)
Pharma's strategic path to growth in the nutra maze
The nutraceutical market is a thriving ecosystem of opportunities. For pharma companies, it's a space where the allure of a $11.55 billion pie by 2030 is tempered by a maze of regulatory grey zones, stiff competition, and trust-eroding marketing practices.
![PRIME NEO from Gandhi Automations PRIME NEO from Gandhi Automations](https://reseuro.magzter.com/100x125/articles/5843/1981257/pSoWQPTC11738587385901/PRIME-NEO-FROM-GANDHI-AUTOMATIONS.jpg)
PRIME NEO from Gandhi Automations
Gandhi Automation's PRIME NEO High Speed Doors are designed to provide superior sealing and resistance to pressure differences for clean rooms. And the added advantage is that it is absolutely washable
![AI smart camera for real-time automation AI smart camera for real-time automation](https://reseuro.magzter.com/100x125/articles/5843/1981257/s351jeUlb1738587298023/AI-SMART-CAMERA-FOR-REALTIME-AUTOMATION.jpg)
AI smart camera for real-time automation
Integrated asset management functionality and a deep learning tool for training and evaluation keep productivity high and costs low
![PROSOLV® 730: Directly compressible carrier for lipophilic ingredients PROSOLV® 730: Directly compressible carrier for lipophilic ingredients](https://reseuro.magzter.com/100x125/articles/5843/1981257/6cppB9bi11738586297726/PROSOLV-730-DIRECTLY-COMPRESSIBLE-CARRIER-FOR-LIPOPHILIC-INGREDIENTS.jpg)
PROSOLV® 730: Directly compressible carrier for lipophilic ingredients
Nearly 90% of molecules in the discovery pipeline and 40% of drugs with market approval are poorly water soluble.
![Complete environmental monitoring solution - testo Saveris Pharma Complete environmental monitoring solution - testo Saveris Pharma](https://reseuro.magzter.com/100x125/articles/5843/1981257/TqM5z0Frt1738587594040/COMPLETE-ENVIRONMENTAL-MONITORING-SOLUTION-TESTO-SAVERIS-PHARMA.jpg)
Complete environmental monitoring solution - testo Saveris Pharma
testo Saveris Pharma monitors and documents temperature, humidity, differential pressure, and other parameters without interruption and compliantly with GxP so that audits and inspections are conducted smoothly
![The unmissable Asia healthcare opportunity The unmissable Asia healthcare opportunity](https://reseuro.magzter.com/100x125/articles/5843/1981257/FkJMEHrta1738583001800/THE-UNMISSABLE-ASIA-HEALTHCARE-OPPORTUNITY.jpg)
The unmissable Asia healthcare opportunity
BCG's latest report, The Unmissable Asia Healthcare Opportunity, highlights the region's $5 trillion healthcare market potential by 2030, driven by demographic shifts, investment, and innovation.
![2025: Healthcare and Lifesciences investment outlook 2025: Healthcare and Lifesciences investment outlook](https://reseuro.magzter.com/100x125/articles/5843/1981257/gni4wTlSk1738585367741/2025-HEALTHCARE-AND-LIFESCIENCES-INVESTMENT-OUTLOOK.jpg)
2025: Healthcare and Lifesciences investment outlook
Kapil Khandelwal, Managing Partner, Toro Finserve and EquNev Capital, interprets the possibilities for the various segments of the Indian lifesciences and healthcare sector for this year
![The group's offerings range from over a billion injection doses annually to bespoke medical machinery The group's offerings range from over a billion injection doses annually to bespoke medical machinery](https://reseuro.magzter.com/100x125/articles/5843/1981257/ytLU7DSi51738579961377/THE-GROUPS-OFFERINGS-RANGE-FROM-OVER-A-BILLION-INJECTION-DOSES-ANNUALLY-TO-BESPOKE-MEDICAL-MACHINERY.jpg)
The group's offerings range from over a billion injection doses annually to bespoke medical machinery
Rishad Dadachanji, MD, Dadachanji Group speaks on the company's evolution from a pharma packaging company to a diversified solutions provider in biotechnology, automation, and sterile processing.
![DECODING THE M&A LANDSCAPE DECODING THE M&A LANDSCAPE](https://reseuro.magzter.com/100x125/articles/5843/1981257/m9-U1Nic21738580242970/DECODING-THE-MA-LANDSCAPE.jpg)
DECODING THE M&A LANDSCAPE
Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing capabilities.
![Evolution and commercialisation of cell and gene therapies Evolution and commercialisation of cell and gene therapies](https://reseuro.magzter.com/100x125/articles/5843/1981257/6TatCW-851738582670742/EVOLUTION-AND-COMMERCIALISATION-OF-CELL-AND-GENE-THERAPIES.jpg)
Evolution and commercialisation of cell and gene therapies
Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global milestones, industry growth, and reimbursement models.